Xanthine Analogs Suppress <i>Trypanosoma cruzi</i> Infection In Vitro Using PDEs as Targets

<i>Trypanosoma cruzi</i> (<i>T. cruzi</i>), the causative agent of Chagas disease, has infected 6 million people, putting 70 million people at risk worldwide. Presently, very limited drugs are available, and these have severe side effects. Hence, there is an urgency to delve into other pathways and...

Descripció completa

Dades bibliogràfiques

Autors principals:	Amita R. Banga, Konjeti R. Sekhar, Kayla J. Rayford, Ashutosh Arun, Peace Odiase, Amar P. Garg, Maria F. Lima, Pius N. Nde, Fernando Villalta, Girish Rachakonda
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2022-09-01
Col·lecció:	Microbiology Research
Matèries:	cAMP cGMP phosphodiesterase (PDE) Chagas disease green fluorescent protein (GFP) <i>Trypanosoma cruzi</i> strains
Accés en línia:	https://www.mdpi.com/2036-7481/13/4/52
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!